In-vitro and in vivo preclinical evaluation of a 5T4 specific antibody–drug conjugate for treating ovarian cancer. (July 2016) - Wan, Y.L.; Sapra, P.; Gilham, D.; Kitchener, H.C.; Stern, P.L.